| N | Stage 0 | Stage 1 | Stage 2 | Stage 3 | Stage 4 |
---|
ApoE-ε4 (+ve) | 58 | 17 (10.5%) | 12 (15.4%) | 15 (37.5%) | 13 (40.6%) | 1 (25.0%) |
ApoE-ε4 (−ve) | 258 | 145 (89.9%) | 66 (84.6%) | 25 (62.5%) | 19 (59.4%) | 3 (75.0%) |
All subjects | 316 | 162 | 78 | 40 | 32 | 4 |
- The table presents the distribution of stageable participants (316 out of 318) in the INSIGHT-preAD cohort among the in vivo amyloid stages and their corresponding ApoE-ε4 status
- N number of participants in each category, ApoE-ε4 apolipoprotein E (ε4 allele)